A survey of diabetes educators reveals challenges faced by patients with diabetes who can’t afford their drugs.
Looking ahead, here are the things most likely to impact managed care.
Authorized generics have been gaining popularity with pharmaceutical manufacturers, but just how do they impact pharmacies?
New report outlines innovative state strategies for managing high-cost Medicaid prescription drugs.
Finding solutions to deliver better outcomes for patients.
How hospitals are using savings from the 340B program to support other programs.
Why lowering drug costs can start with machine learning and better patient interaction.
A record number of new oncology treatments launched in the US last year and spending on cancer drugs soared. Here are the top 6 cancer drug trends revealed in the report.
The real-world strategies used to manage the high cost of specialty meds.
The Trump Administration has taken a large interest in PBM drug rebates, which they say create higher drug prices. But do they?